Center for Metabolic and Vascular Biology and School of Life Sciences, Arizona State University, Scottsdale, Arizona.
College of Medicine, Mayo Clinic in Arizona, Scottsdale, Arizona.
Am J Physiol Endocrinol Metab. 2020 Apr 1;318(4):E538-E553. doi: 10.1152/ajpendo.00463.2019. Epub 2020 Jan 28.
Mitochondria from skeletal muscle of humans with obesity often display alterations with respect to their morphology, proteome, biogenesis, and function. These changes in muscle mitochondria are considered to contribute to metabolic abnormalities observed in humans with obesity. Most of the evidence describing alterations in muscle mitochondria in humans with obesity, however, lacks reference to a specific subcellular location. This is despite data over the years showing differences in the morphology and function of subsarcolemmal (found near the plasma membrane) and intermyofibrillar (nested between the myofibrils) mitochondria in skeletal muscle. Recent studies reveal that impairments in mitochondrial function in obesity with respect to the subcellular location of the mitochondria in muscle are more readily evident following exposure of the skeletal muscle to physiological stimuli. In this review, we highlight the need to understand skeletal muscle mitochondria metabolism in obesity in a subpopulation-specific manner and in the presence of physiological stimuli that modify mitochondrial function in vivo. Experimental approaches employed under these conditions will allow for more precise characterization of impairments in skeletal muscle mitochondria and their implications in inducing metabolic dysfunction in human obesity.
肥胖人群的骨骼肌线粒体通常在形态、蛋白质组、生物发生和功能方面表现出改变。这些肌肉线粒体的变化被认为有助于肥胖人群中观察到的代谢异常。然而,描述肥胖人群肌肉线粒体改变的大多数证据都没有参考特定的亚细胞位置。尽管多年来的数据显示骨骼肌中靠近质膜的肌膜下(位于质膜附近)和肌纤维间(嵌套在肌纤维之间)线粒体的形态和功能存在差异。最近的研究表明,在骨骼肌暴露于生理刺激后,肥胖症中线粒体在亚细胞位置上的功能障碍更容易显现。在这篇综述中,我们强调需要以特定亚群的方式理解肥胖症中的骨骼肌线粒体代谢,并在能够改变体内线粒体功能的生理刺激存在的情况下进行理解。在这些条件下采用的实验方法将允许更精确地描述骨骼肌线粒体的损伤及其在诱导人类肥胖代谢功能障碍中的意义。